Diagnostic value of Ki-67 and repp 86 in distinction between benign and malignant mesothelial proliferations Source: Eur Respir J 2006; 28: Suppl. 50, 784s Year: 2006
The diagnostic value of mucinous carcinoma - associated antigen (MCA) testin differentiation of malignant from benign pleural effusion (PE) Source: Eur Respir J 2003; 22: Suppl. 45, 61s Year: 2003
Expression of immunohistochemical markers chromogranin A, Ki-67, CD99, EGFR in resected pulmonary neuroendocrine tumors Source: Annual Congress 2011 - Progress in pathology of lung cancer Year: 2011
The clinical effect and expression of alpha-methylacyl-CoA racemace (AMACR) in the differential diagnosis of malign mesothelioma and adenocarcinoma of lung Source: Annual Congress 2012 - New aspects of lung cancer biology Year: 2012
Tumor markers (TM) CEA, CYFRA 21-1,MCA and NSE in pleural effusion(PE) at malignant mezothelioma and metastatic tumor of pleura Source: Eur Respir J 2002; 20: Suppl. 38, 439s Year: 2002
CEA, Cyfra 21.1 and NSE levels in malignant and benign pleural effusion Source: Eur Respir J 2002; 20: Suppl. 38, 273s Year: 2002
Expression of c-met in malignant pleural mesothelioma; an immunohistochemical study Source: Annual Congress 2007 - Inorganic dust "old timers and new kids on the block" Year: 2007
MonoTotal vs. other cytokeratin markers in NSCLC Source: Annual Congress 2008 - Various aspects of thoracic oncology Year: 2008
Diagnostic utility of CYFRA 21-1 and carcinoembryonic antigen as a tumour markers in malignant pleural effusions Source: Eur Respir J 2001; 18: Suppl. 33, 397s Year: 2001
The value of immunohistochemical markers in the differential diagnosis of adenocarcinomas Source: Annual Congress 2011 - Quality management for lung cancer patients Year: 2011
Four cases of histopathologically confirmed lung epithelioid hemangioendothelioma (EHE) Source: Eur Respir J 2004; 24: Suppl. 48, 532s Year: 2004
The usefulness of Cyfra 21-1 as a disease marker in malignant pleural mesothelioma (MPM) Source: Eur Respir J 2006; 28: Suppl. 50, 85s Year: 2006
Telomerase as an immunohistochemical marker for differentiation between reactive and neoplastic pleural lesions? Source: Eur Respir J 2003; 22: Suppl. 45, 60s Year: 2003
Distinction in immunoprofile of unusual lung tumours Source: Annual Congress 2007 - Biology of thoracic malignancies Year: 2007
What is a rare tumour and how should it be dealt with clinically? Source: ISSN=ISSN 1025-448x, ISBN=ISBN 978-1-904097-51-8, page=85 Year: 2007
Detection of mesothelin in the pleural effusion has a higher diagnostic utility than in serum for diagnostic of malignant mesothelioma Source: Annual Congress 2013 –Clinical problems in mediastinal and pleural malignacies Year: 2013
Coexpression of Ki-67 and PCNA in precancer lesions in chronic diffuse lung diseases (CDLD) as a predictor of their malignant potential Source: Eur Respir J 2001; 18: Suppl. 33, 19s Year: 2001
Contribution of immunohistochemical (IHC) markers to the diagnosis of pulmonary carcinoids Source: Annual Congress 2011 - Lung cancer: molecular pathology and functional genomics Year: 2011
The differential diagnosis of pulmonary pre-invasive lesions Source: ISSN=ISSN 1025-448x, ISBN=ISBN 978-1-904097-51-8, page=37 Year: 2007
Different prevalence of positivity for human mammaglobin (hMAM) transcipts in the pleural fluid of patients with malignant vs. non malignant pleural disease Source: Eur Respir J 2006; 28: Suppl. 50, 580s Year: 2006